Is Carl Zeiss Meditec AG (CZMWF) a Buy, Sell, or Hold?
OTC : CZMWF
Carl Zeiss Meditec AG
$33.5 USD
$0 (0.0%)
- Volume
- 100
- Average Volume
- 132
- Market Capitalization
- $2.93B
- P/E Ratio
- 20.43
- Dividend Yield
- 1.98%
- Price Target
- Year High
- $59.40
- Year Low
- $26.42
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.54
- Current Ratio
- $2.43
Company Overview
OTC
Andreas Pecher
Medical - Specialties
Healthcare
CZMWF
5798
DE
USD
Liquidity Metrics
0.29
2.43
1.37
0.05
0.54
Sales & Valuation
$2.23B
0.92
1.16
6.57
4.23
Profitability
$1.61
$141.21M
3.41%
4.68%
4.27%
2.69%
P/E Metrics
20.43
-0.87
-0.87
Analyst Price Target & Rating
3/5
0 Analysts
%
Financial Health Scores
3.33
6/9
$727.33M
$3.35B
$1.24B
$231.19M
Key Metrics (TTM)
$3.11B
1.18
10.25
2.43
4.27%
4.08%
3.57%
14.71%
$23.54
206 days
Company Executives
| Name | Title |
|---|---|
| Magnus Reibenspiess | Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology |
| Euan S. Thomson | President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit |
| Christian Munster | Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board |
| Steven C. Schallhorn | Chief Medical Officer for Global Ophthalmic Devices |
| Andrew Chang | Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc. |
| Justus Felix Wehmer | Chief Financial Officer & Member of the Management Board |
| Stefanie Spanagel | Chief Operating Officer |
| Eva-Maria Heine | Chief Human Resources Officer |
| Andreas Pecher | Interim Chairman of the Management Board & Interim CEO |
| Sebastian Frericks | Director of Investor Relations |
Poll Results
No votes yet today — be the first to share your view!
About Carl Zeiss Meditec AG (OTC:CZMWF) Stock
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using le ... nticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.
Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript
2026-05-13 22:40:44
Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript
Carl Zeiss Meditec Q2 Earnings Call Highlights
2026-05-12 06:10:17
Carl Zeiss Meditec ETR: AFX reported weaker first-half results for fiscal 2025/2026 and outlined a broad restructuring plan aimed at restoring profitability over the next three years, as management pointed to currency headwinds, soft equipment demand and pressure in China's intraocular lens business.
Carl Zeiss Meditec: Bad Optics But With 'Buy' Potential
2026-04-21 17:42:02
Carl Zeiss Meditec AG is rated a "Buy" despite recent operational weakness and geopolitical headwinds, especially in Asia-Pacific and North America. Sales declined 4.8% in Q1, with margin compression and a suspended 2025/2026 outlook due to weak demand across Asia-Pacific and North America. CZMWF now trades at a significant discount to peers, with a 2026 price target of $39.26, implying ~20% upside against a discounted multiple.
Frequently Asked Questions
-
What is the current Carl Zeiss Meditec AG (CZMWF) stock price?
-
Carl Zeiss Meditec AG(OTC:CZMWF) stock price is $33.5 in the last trading session. During the trading session, CZMWF stock reached the peak price of $59.4 while $26.42 was the lowest point it dropped to. The percentage change in CZMWF stock occurred in the recent session was 0.0% while the dollar amount for the price change in CZMWF stock was $0.
-
CZMWF's industry and sector of operation?
-
The OTC listed CZMWF is part of Medical - Specialties industry that operates in the broader Healthcare sector.
-
Who are the executives of CZMWF?
-
Magnus Reibenspiess | Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology
Euan S. Thomson | President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit
Christian Munster | Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board
Steven C. Schallhorn | Chief Medical Officer for Global Ophthalmic Devices
Andrew Chang | Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc. -
How many employees does CZMWF have?
-
Number of CZMWF employees currently stands at 5798. CZMWF operates from Göschwitzer Straße 51-52, Jena, TH 07745, DE.
-
Link for CZMWF official website?
-
Official Website of CZMWF is: https://www.zeiss.com
-
How do I contact CZMWF?
-
CZMWF could be contacted at phone #49 3641 2200 and can also be accessed through its website. CZMWF operates from Göschwitzer Straße 51-52, Jena, TH 07745, DE.
-
How many shares of CZMWF are traded daily?
-
The average number of CZMWF shares traded daily for last 3 months was 132.
-
What is the market cap of CZMWF currently?
-
The market value of CZMWF currently stands at $2.93B with its latest stock price at $33.5